Surmodics, Inc. (SRDX)
USD 29.25
(-2.86%)
USD 29.25
(-2.86%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 29.4 Million USD | 665.16% |
| 2022 | 3.84 Million USD | 20.55% |
| 2021 | 3.18 Million USD | -4.55% |
| 2020 | 3.34 Million USD | 243.78% |
| 2019 | -2.32 Million USD | -49.01% |
| 2018 | -1.55 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 100.0% |
| 2003 | -1.64 Million USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 32.87 Million USD | 0.13% |
| 2024 Q3 | 29.51 Million USD | 0.13% |
| 2024 Q2 | 29.48 Million USD | 0.13% |
| 2023 Q3 | 32.41 Million USD | 10.61% |
| 2023 Q4 | 29.4 Million USD | -9.28% |
| 2023 FY | 29.4 Million USD | 665.16% |
| 2023 Q1 | 29.49 Million USD | 667.5% |
| 2023 Q2 | 29.3 Million USD | -0.65% |
| 2022 Q1 | 3.25 Million USD | 2.23% |
| 2022 Q2 | 4.3 Million USD | 32.03% |
| 2022 Q3 | 4.1 Million USD | -4.62% |
| 2022 Q4 | 3.84 Million USD | -6.36% |
| 2022 FY | 3.84 Million USD | 20.55% |
| 2021 Q1 | 3.41 Million USD | 2.13% |
| 2021 FY | 3.18 Million USD | -4.55% |
| 2021 Q2 | 3.29 Million USD | -3.46% |
| 2021 Q4 | 3.18 Million USD | -4.0% |
| 2021 Q3 | 3.32 Million USD | 0.85% |
| 2020 Q3 | 3.28 Million USD | 9.21% |
| 2020 Q2 | 3 Million USD | 25.69% |
| 2020 Q1 | 2.39 Million USD | 0.0% |
| 2020 FY | 3.34 Million USD | 243.78% |
| 2020 Q4 | 3.34 Million USD | 1.64% |
| 2019 Q3 | - USD | 0.0% |
| 2019 FY | -2.32 Million USD | -49.01% |
| 2019 Q2 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | -1.55 Million USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2004 Q3 | - USD | 100.0% |
| 2004 FY | - USD | 100.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q1 | - USD | 100.0% |
| 2004 Q2 | -1.58 Million USD | 0.0% |
| 2003 FY | -1.64 Million USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q4 | -1.64 Million USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 Q4 | - USD | -100.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q3 | 125 Thousand USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 18.55% |
| BrainsWay Ltd. | 239 Thousand USD | -12203.347% |
| Cerus Corporation | 59.79 Million USD | 50.824% |
| Envoy Medical, Inc. | 404 Thousand USD | -7178.465% |
| electroCore, Inc. | 537 Thousand USD | -5375.791% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -244941.667% |
| IceCure Medical Ltd | 376 Thousand USD | -7720.479% |
| Inogen, Inc. | 18.27 Million USD | -60.947% |
| OrthoPediatrics Corp. | 13.45 Million USD | -118.478% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -14676.382% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -7984.427% |
| MaxCyte, Inc. | 17.96 Million USD | -63.643% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -53088.988% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 68.418% |
| PAVmed Inc | 2.96 Million USD | -893.412% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -373.206% |
| RxSight, Inc. | 1.21 Million USD | -2328.159% |
| Sight Sciences, Inc. | 31.7 Million USD | 7.263% |
| SI-BONE, Inc. | 36.06 Million USD | 18.467% |
| TELA Bio, Inc. | 40.51 Million USD | 27.422% |
| Treace Medical Concepts, Inc. | 53 Million USD | 44.527% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -1833.268% |
| Acutus Medical, Inc. | 32.65 Million USD | 9.95% |
| Talis Biomedical Corporation | 16.78 Million USD | -75.176% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -626.947% |
| CVRx, Inc. | 30.38 Million USD | 3.216% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -2791.546% |
| Bioventus Inc. | 366.99 Million USD | 91.988% |
| Venus Concept Inc. | 70.79 Million USD | 58.462% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -2263.746% |
| LivaNova PLC | 568.54 Million USD | 94.828% |
| 908 Devices Inc. | 3.92 Million USD | -648.409% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 94.246% |
| Nemaura Medical Inc. | 3.08 Million USD | -852.342% |
| NeuroPace, Inc. | 56.95 Million USD | 48.371% |
| LENSAR, Inc. | 1.75 Million USD | -1580.286% |
| Apyx Medical Corporation | 33.18 Million USD | 11.391% |
| Cutera, Inc. | 418.69 Million USD | 92.977% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | -95.46% |
| BioSig Technologies, Inc. | 103 Thousand USD | -28448.544% |
| Anika Therapeutics, Inc. | 26.9 Million USD | -9.296% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -195.557% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 98.02% |
| Axonics, Inc. | 25.84 Million USD | -13.796% |
| Outset Medical, Inc. | 134.59 Million USD | 78.153% |
| IRIDEX Corporation | 1.75 Million USD | -1579.326% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 42.724% |
| IRadimed Corporation | 1.61 Million USD | -1720.653% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -16607.386% |
| INVO Bioscience, Inc. | 6.77 Million USD | -333.953% |
| Telesis Bio, Inc. | 5.26 Million USD | -458.076% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -392.44% |
| Varex Imaging Corporation | 464.2 Million USD | 93.665% |
| Quipt Home Medical Corp. | 60.82 Million USD | 51.653% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -4900.85% |
| Pulmonx Corporation | 35.08 Million USD | 16.199% |
| Dynatronics Corporation | 3.25 Million USD | -802.415% |
| Modular Medical, Inc. | 817 Thousand USD | -3499.143% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -19373.51% |
| Semler Scientific, Inc. | 70 Thousand USD | -41907.143% |
| InMode Ltd. | 6.61 Million USD | -344.654% |
| Bruker Corporation | 1.14 Billion USD | 97.431% |
| Cytosorbents Corporation | 2.54 Million USD | -1056.376% |
| DexCom, Inc. | 2.57 Billion USD | 98.857% |
| Align Technology, Inc. | 96.96 Million USD | 69.676% |
| Viveve Medical, Inc. | 5.12 Million USD | -473.868% |
| ZimVie Inc. | 508.79 Million USD | 94.221% |
| Movano Inc. | 15.00 USD | -196033233.333% |
| Cytek Biosciences, Inc. | 18.12 Million USD | -62.234% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 92.623% |
| Profound Medical Corp. | 4.97 Million USD | -491.124% |
| Insulet Corporation | 1.36 Billion USD | 97.848% |
| enVVeno Medical Corporation | 1.06 Million USD | -2663.628% |
| iCAD, Inc. | 273 Thousand USD | -10671.062% |
| Nuwellis, Inc. | 221 Thousand USD | -13205.43% |
| Biotricity, Inc. | 10.85 Million USD | -170.868% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 15.866% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -4425.58% |
| InspireMD, Inc. | 1.03 Million USD | -2732.852% |
| PAVmed Inc. | 2.96 Million USD | -893.412% |
| BIOLASE, Inc. | 13.98 Million USD | -110.261% |
| Beyond Air, Inc. | 14.72 Million USD | -99.749% |
| FONAR Corporation | 37.92 Million USD | 22.474% |
| AxoGen, Inc. | 46.6 Million USD | 36.903% |
| Vivani Medical, Inc. | 19.31 Million USD | -52.255% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 34.087% |
| Inari Medical, Inc. | 30.35 Million USD | 3.13% |
| UFP Technologies, Inc. | 28 Million USD | -5.018% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -6674.643% |
| Tenon Medical, Inc. | 428 Thousand USD | -6770.327% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -2834.631% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -1266.289% |
| AdaptHealth Corp. | 2.09 Billion USD | 98.596% |
| Sintx Technologies, Inc. | 3.68 Million USD | -697.532% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 21.003% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -4900.85% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -4833.725% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 96.704% |
| TransMedics Group, Inc. | 506.2 Million USD | 94.191% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -4744.316% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -31694.345% |
| Hyperfine, Inc. | 64 Thousand USD | -45845.313% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 84.42% |
| Biomerica, Inc. | 459 Thousand USD | -6306.318% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -6441.96% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -15377.375% |
| Silk Road Medical, Inc | 75.62 Million USD | 61.118% |